Hospital Universitario Arnau de Vilanova -ko ikertzaileekin lankidetzan egindako argitalpenak (24)

2024

  1. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  2. Sleep quality in individuals with post-COVID-19 condition: Relation with emotional, cognitive and functional variables

    Brain, Behavior, and Immunity - Health, Vol. 35

2023

  1. Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 123

  2. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  3. Editorial: The underlying relationship between sleep and neurodegenerative diseases

    Frontiers in Neuroscience

2022

  1. Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  2. Clinical impact of microbleeds in patients with Alzheimer’s disease

    BMC Geriatrics, Vol. 22, Núm. 1

2021

  1. Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease

    Sleep, Vol. 44, Núm. 2

  2. Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s Disease

    Frontiers in Aging Neuroscience, Vol. 13

  3. Sleep profile predicts the cognitive decline of mild-moderate Alzheimer's disease patients

    Sleep, Vol. 44, Núm. 10

  4. The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients

    Alzheimer's Research and Therapy, Vol. 13, Núm. 1

2020

  1. Circulating MicroRNA Profile Associated with Obstructive Sleep Apnea in Alzheimer’s Disease

    Molecular Neurobiology, Vol. 57, Núm. 11, pp. 4363-4372

  2. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1

  3. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID-19 lockdown

    European Journal of Neurology, Vol. 27, Núm. 9, pp. 1744-1747

  4. Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer’s disease

    European Respiratory Journal, Vol. 56, Núm. 5

  5. Prevalence of obstructive sleep apnea in Alzheimer’s disease patients

    Journal of Neurology, Vol. 267, Núm. 4, pp. 1012-1022

2019

  1. High BDNF serum levels are associated to good cognitive functioning in bipolar disorder

    European Psychiatry, Vol. 60, pp. 97-107

  2. The STOP-Bang and Berlin questionnaires to identify obstructive sleep apnoea in Alzheimer's disease patients

    Sleep Medicine, Vol. 57, pp. 15-20

2015

  1. Prediction of myocardial infarction in patients with transient ischaemic attack

    Acta Neurologica Scandinavica, Vol. 131, Núm. 2, pp. 111-119

2014

  1. N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation

    European Journal of Neurology, Vol. 21, Núm. 4, pp. 679-683